Korean J Gastroenterol.  2014 Jun;63(6):333-334. 10.4166/kjg.2014.63.6.333.

Does Positron Emission Tomography-Computed Tomography Maximum Standardized Uptake Value Predict Survival in Surgically Resected Gastric Cancer?

Affiliations
  • 1Department of Internal Medicine, Jeju National University School of Medicine, Jeju, Korea. songhj@jejunu.ac.kr

Abstract

No abstract available.


MeSH Terms

Female
Humans
Male
Stomach Neoplasms/*diagnosis

Reference

References

1. Shin A, Kim J, Park S. Gastric cancer epidemiology in Korea. J Gastric Cancer. 2011; 11:135–140.
Article
2. Yoon NR, Park JM, Jung HS, et al. Usefulness of 18F-fluoro-2-de-oxyglucose positron emission tomography in evaluation of gastric cancer stage. Korean J Gastroenterol. 2012; 59:347–353.
3. Shimada H, Okazumi S, Koyama M, Murakami K. Japanese Gastric Cancer Association Task Force for Research Promotion: clinical utility of 18F-fluoro-2-deoxyglucose positron emission tomography in gastric cancer. A systematic review of the literature. Gastric Cancer. 2011; 14:13–21.
Article
4. Kim EY, Lee WJ, Choi D, et al. The value of PET/CT for pre-operative staging of advanced gastric cancer: comparison with contrast-enhanced CT. Eur J Radiol. 2011; 79:183–188.
Article
5. Ozkan E, Araz M, Soydal C, Kucuk ON. The role of 18F-FDG-PET/CT in the preoperative staging and posttherapy follow up of gastric cancer: comparison with spiral CT. World J Surg Oncol. 2011; 9:75.
Article
6. Park MJ, Lee WJ, Lim HK, Park KW, Choi JY, Kim BT. Detecting recurrence of gastric cancer: the value of FDG PET/CT. Abdom Imaging. 2009; 34:441–447.
Article
7. Sim SH, Kim YJ, Oh DY, et al. The role of PET/CT in detection of gastric cancer recurrence. BMC Cancer. 2009; 9:73.
Article
8. Dassen AE, Lips DJ, Hoekstra CJ, Pruijt JF, Bosscha K. FDG-PET has no definite role in preoperative imaging in gastric cancer. Eur J Surg Oncol. 2009; 35:449–455.
Article
9. Ha TK, Choi YY, Song SY, Kwon SJ. F18-fluorodeoxyglucose-positron emission tomography and computed tomography is not accurate in preoperative staging of gastric cancer. J Korean Surg Soc. 2011; 81:104–110.
Article
10. Lee JE, Hong SP, Ahn DH, et al. The role of 18F-FDG PET/CT in the evaluation of gastric cancer recurrence after curative gastrectomy. Yonsei Med J. 2011; 52:81–88.
11. Hur H, Kim SH, Kim W, Song KY, Park CH, Jeon HM. The efficacy of preoperative PET/CT for prediction of curability in surgery for locally advanced gastric carcinoma. World J Surg Oncol. 2010; 8:86.
Article
12. Kim KS, Choi SR, Park IC, Koo TH, Kim JM. Prognostic value of preoperative positron emission tomography-computed tomography in surgically resected gastric cancer. Korean J Gastroenterol. 2014; 63:348–353.
Article
13. Park JC, Lee JH, Cheoi K, et al. Predictive value of pretreatment metabolic activity measured by fluorodeoxyglucose positron emission tomography in patients with metastatic advanced gastric cancer: the maximal SUV of the stomach is a prognostic factor. Eur J Nucl Med Mol Imaging. 2012; 39:1107–1116.
Article
14. Lee JW, Lee SM, Lee MS, Shin HC. Role of 18F-FDG PET/CT in the prediction of gastric cancer recurrence after curative surgical resection. Eur J Nucl Med Mol Imaging. 2012; 39:1425–1434.
Article
15. Oh HH, Lee SE, Choi IS, et al. The peak-standardized uptake value (P-SUV) by preoperative positron emission tomography-comput-ed tomography (PET-CT) is a useful indicator of lymph node metastasis in gastric cancer. J Surg Oncol. 2011; 104:530–533.
Article
Full Text Links
  • KJG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr